AU2002323873A1 - Active ingredient combination of E.G. galanthamine or deoxypeganine and E.G. acamprosate or memantine for treating an addiction such as alcoholism - Google Patents
Active ingredient combination of E.G. galanthamine or deoxypeganine and E.G. acamprosate or memantine for treating an addiction such as alcoholismInfo
- Publication number
- AU2002323873A1 AU2002323873A1 AU2002323873A AU2002323873A AU2002323873A1 AU 2002323873 A1 AU2002323873 A1 AU 2002323873A1 AU 2002323873 A AU2002323873 A AU 2002323873A AU 2002323873 A AU2002323873 A AU 2002323873A AU 2002323873 A1 AU2002323873 A1 AU 2002323873A1
- Authority
- AU
- Australia
- Prior art keywords
- deoxypeganine
- acamprosate
- galanthamine
- memantine
- alcoholism
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- ASUTZQLVASHGKV-JDFRZJQESA-N Galantamine Chemical compound O1C(=C23)C(OC)=CC=C2CN(C)CC[C@]23[C@@H]1C[C@@H](O)C=C2 ASUTZQLVASHGKV-JDFRZJQESA-N 0.000 title 2
- 208000007848 Alcoholism Diseases 0.000 title 1
- WUFQLZTXIWKION-UHFFFAOYSA-N Deoxypeganine Chemical compound C1C2=CC=CC=C2N=C2N1CCC2 WUFQLZTXIWKION-UHFFFAOYSA-N 0.000 title 1
- 206010012335 Dependence Diseases 0.000 title 1
- 229960003980 Galantamine Drugs 0.000 title 1
- BUGYDGFZZOZRHP-UHFFFAOYSA-N Memantine Chemical compound C1C(C2)CC3(C)CC1(C)CC2(N)C3 BUGYDGFZZOZRHP-UHFFFAOYSA-N 0.000 title 1
- AFCGFAGUEYAMAO-UHFFFAOYSA-N acamprosate Chemical compound CC(=O)NCCCS(O)(=O)=O AFCGFAGUEYAMAO-UHFFFAOYSA-N 0.000 title 1
- 229960004047 acamprosate Drugs 0.000 title 1
- 239000004480 active ingredient Substances 0.000 title 1
- 201000007930 alcohol dependence Diseases 0.000 title 1
- 229960004640 memantine Drugs 0.000 title 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10129265.1 | 2001-06-18 | ||
| DE10129265A DE10129265A1 (en) | 2001-06-18 | 2001-06-18 | Active ingredient combination for drug addiction or intoxicant therapy |
| PCT/EP2002/006630 WO2002102388A2 (en) | 2001-06-18 | 2002-06-15 | Active ingredient combination of e.g. galanthamine or deoxypeganine and e.g. acamprosate or memantine for treating an addiction such as alcoholism |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2002323873A1 true AU2002323873A1 (en) | 2003-05-15 |
| AU2002323873B2 AU2002323873B2 (en) | 2006-11-16 |
Family
ID=7688529
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002323873A Ceased AU2002323873B2 (en) | 2001-06-18 | 2002-06-15 | Active ingredient combination of E.G. galanthamine or deoxypeganine and E.G. acamprosate or memantine for treating an addiction such as alcoholism |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US20040192683A1 (en) |
| EP (1) | EP1397138B1 (en) |
| JP (1) | JP2005500298A (en) |
| KR (1) | KR20040010744A (en) |
| CN (1) | CN1527711A (en) |
| AR (1) | AR034493A1 (en) |
| AT (1) | ATE286397T1 (en) |
| AU (1) | AU2002323873B2 (en) |
| BR (1) | BR0211008A (en) |
| CA (1) | CA2450787C (en) |
| CZ (1) | CZ299951B6 (en) |
| DE (2) | DE10129265A1 (en) |
| EA (1) | EA006647B1 (en) |
| ES (1) | ES2236551T3 (en) |
| HK (1) | HK1063292A1 (en) |
| HU (1) | HUP0400865A3 (en) |
| IL (2) | IL159345A0 (en) |
| MX (1) | MXPA03011825A (en) |
| MY (1) | MY129726A (en) |
| NO (1) | NO20035458D0 (en) |
| NZ (1) | NZ529944A (en) |
| PL (1) | PL367207A1 (en) |
| PT (1) | PT1397138E (en) |
| SK (1) | SK287180B6 (en) |
| TW (1) | TWI325320B (en) |
| UA (1) | UA76753C2 (en) |
| WO (1) | WO2002102388A2 (en) |
| ZA (1) | ZA200309232B (en) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10134038A1 (en) * | 2001-07-12 | 2003-02-06 | Hf Arzneimittelforsch Gmbh | Active ingredient combination for drug therapy of nicotine addiction |
| DE10318714B4 (en) * | 2003-04-25 | 2006-03-23 | Hf Arzneimittelforschung Gmbh | Drug combinations and therapies to combat alcohol abuse |
| DE10354894A1 (en) * | 2003-11-24 | 2005-07-07 | Hf Arzneimittelforschung Gmbh | Oral formulations of deoxypeganine and their applications |
| DE102004048927A1 (en) * | 2004-10-06 | 2006-04-20 | Lts Lohmann Therapie-Systeme Ag | Pharmaceutical combination containing deoxypeganine and Cyp2D6 inhibitors |
| US7619007B2 (en) | 2004-11-23 | 2009-11-17 | Adamas Pharmaceuticals, Inc. | Method and composition for administering an NMDA receptor antagonist to a subject |
| CA2604052C (en) | 2005-04-06 | 2014-07-08 | Adamas Pharmaceuticals, Inc. | Methods and compositions for the treatment of cns-related conditions |
| US8632800B2 (en) * | 2005-05-13 | 2014-01-21 | Alza Corporation | Multilayer drug delivery system with barrier against reservoir material flow |
| BRPI0615312A2 (en) | 2005-09-01 | 2012-12-04 | Mitsubishi Chem Corp | apparatus for heat treatment of polyester particles and multi-stage solid phase polycondensation methods for polyester particles and for the production of a polyester and a polyethylene terephthalate |
| US20070104771A1 (en) * | 2005-09-23 | 2007-05-10 | Jay Audett | Transdermal galantamine delivery system |
| PT2395990E (en) | 2009-02-12 | 2015-02-09 | Univ Indiana Res & Tech Corp | Material and methods for treating developmental disorders including comorbid and idiopathic autism |
| MX365650B (en) | 2009-12-02 | 2019-06-10 | Adamas Pharmaceuticals Inc | Amantadine compositions and methods of use. |
| EP2621487B1 (en) | 2010-09-28 | 2017-05-03 | Depomed, Inc. | Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract |
| BR112013013390A2 (en) * | 2010-12-03 | 2016-09-06 | Orexigen Therapeutics Inc | increased drug bioavailability in naltrexone therapy |
| WO2013160728A1 (en) | 2012-04-26 | 2013-10-31 | Alma Mater Studiorum - Universita' Di Bologna | Dual targeting compounds for the treatment of alzheimer's disease |
| US10154971B2 (en) | 2013-06-17 | 2018-12-18 | Adamas Pharma, Llc | Methods of administering amantadine |
| TWI678202B (en) * | 2016-12-14 | 2019-12-01 | 陸汝斌 | Use of composition for preparing drug for treating alcohol dependence or alcohol abuse |
| BR112020003375A2 (en) | 2017-08-24 | 2020-08-25 | Adamas Pharma, Llc | amantadine compositions, preparations thereof, and methods of use |
| BG67408B1 (en) * | 2019-04-12 | 2022-01-17 | Софарма Ад | Oral drug composition with plant alkaloid for treatment of addictions |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3797494A (en) * | 1969-04-01 | 1974-03-19 | Alza Corp | Bandage for the administration of drug by controlled metering through microporous materials |
| US3742951A (en) * | 1971-08-09 | 1973-07-03 | Alza Corp | Bandage for controlled release of vasodilators |
| US3996934A (en) * | 1971-08-09 | 1976-12-14 | Alza Corporation | Medical bandage |
| US4031894A (en) * | 1975-12-08 | 1977-06-28 | Alza Corporation | Bandage for transdermally administering scopolamine to prevent nausea |
| DE3315272C2 (en) * | 1983-04-27 | 1986-03-27 | Lohmann Gmbh & Co Kg, 5450 Neuwied | Pharmaceutical product and process for its manufacture |
| DE3843239C1 (en) * | 1988-12-22 | 1990-02-22 | Lohmann Therapie Syst Lts | |
| EP0424179A3 (en) * | 1989-10-20 | 1991-12-27 | John William Olney | Use of combined excitatory amino acid and cholinergic antagonists to prevent neurological deterioration |
| DE4010079A1 (en) * | 1990-03-29 | 1991-10-02 | Lohmann Therapie Syst Lts | PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF ALCOHOLISM |
| US5519017A (en) * | 1990-03-29 | 1996-05-21 | Lts Lohmann Therapie-Systeme Gmbh + Co. Kg | Pharmaceutic formulation for the treatment of alcoholism |
| US5668117A (en) * | 1991-02-22 | 1997-09-16 | Shapiro; Howard K. | Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments |
| ES2106700T3 (en) * | 1994-10-21 | 2000-05-16 | Sanochemia Pharmazeutika Ag | PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF 4A, 5,9,10,11,12-HEXAHIDRO-6H-BENZOFURO (3A, 3,2-EF) (2) BENZACEPINAS. |
| DE19509663A1 (en) * | 1995-03-17 | 1996-09-19 | Lohmann Therapie Syst Lts | Process for the isolation of galanthamine |
| GB9514821D0 (en) * | 1995-07-19 | 1995-09-20 | Sod Conseils Rech Applic | Galanthamine derivatives |
| AT403803B (en) * | 1996-04-19 | 1998-05-25 | Sanochemia Ltd | NEW BENZAZEPINE DERIVATIVES, THESE MEDICINAL PRODUCTS AND THE USE THEREOF FOR THE PRODUCTION OF MEDICINAL PRODUCTS |
| EP0945133A1 (en) * | 1998-03-26 | 1999-09-29 | Lipha | Combination for the treatment of alcohol and drug dependence containing an opioid antagonist and a NMDA receptor complex modulator |
| BR9910130A (en) * | 1998-04-17 | 2001-01-09 | Kenneth Curry | Cuban derivatives as metabotropic glutamate receptor antagonists and process for their preparation |
| DE19906978B4 (en) * | 1999-02-19 | 2004-07-08 | Lts Lohmann Therapie-Systeme Ag | Pharmaceutical composition containing deoxypeganine for the treatment of drug dependence |
| DE19906979B4 (en) * | 1999-02-19 | 2004-07-08 | Lts Lohmann Therapie-Systeme Ag | Use of deoxypeganine for the treatment of nicotine addiction |
| DE19906974C2 (en) * | 1999-02-19 | 2003-10-09 | Lohmann Therapie Syst Lts | Use of deoxypeganine for the treatment of alcoholism |
-
2001
- 2001-06-18 DE DE10129265A patent/DE10129265A1/en not_active Withdrawn
-
2002
- 2002-06-14 AR ARP020102244A patent/AR034493A1/en unknown
- 2002-06-15 NZ NZ529944A patent/NZ529944A/en unknown
- 2002-06-15 AU AU2002323873A patent/AU2002323873B2/en not_active Ceased
- 2002-06-15 IL IL15934502A patent/IL159345A0/en active IP Right Grant
- 2002-06-15 CZ CZ20033390A patent/CZ299951B6/en not_active IP Right Cessation
- 2002-06-15 PT PT02754688T patent/PT1397138E/en unknown
- 2002-06-15 US US10/480,287 patent/US20040192683A1/en not_active Abandoned
- 2002-06-15 DE DE50201958T patent/DE50201958D1/en not_active Expired - Lifetime
- 2002-06-15 EP EP02754688A patent/EP1397138B1/en not_active Expired - Lifetime
- 2002-06-15 KR KR10-2003-7016570A patent/KR20040010744A/en active Search and Examination
- 2002-06-15 BR BR0211008-3A patent/BR0211008A/en not_active Application Discontinuation
- 2002-06-15 UA UA20031211802A patent/UA76753C2/en unknown
- 2002-06-15 AT AT02754688T patent/ATE286397T1/en not_active IP Right Cessation
- 2002-06-15 PL PL02367207A patent/PL367207A1/en unknown
- 2002-06-15 WO PCT/EP2002/006630 patent/WO2002102388A2/en active IP Right Grant
- 2002-06-15 MX MXPA03011825A patent/MXPA03011825A/en active IP Right Grant
- 2002-06-15 EA EA200400041A patent/EA006647B1/en not_active IP Right Cessation
- 2002-06-15 HU HU0400865A patent/HUP0400865A3/en unknown
- 2002-06-15 ES ES02754688T patent/ES2236551T3/en not_active Expired - Lifetime
- 2002-06-15 CA CA002450787A patent/CA2450787C/en not_active Expired - Fee Related
- 2002-06-15 SK SK1565-2003A patent/SK287180B6/en not_active IP Right Cessation
- 2002-06-15 CN CNA028110196A patent/CN1527711A/en active Pending
- 2002-06-15 JP JP2003504974A patent/JP2005500298A/en active Pending
- 2002-06-17 TW TW091113176A patent/TWI325320B/en not_active IP Right Cessation
- 2002-06-17 MY MYPI20022245A patent/MY129726A/en unknown
-
2003
- 2003-11-27 ZA ZA200309232A patent/ZA200309232B/en unknown
- 2003-12-08 NO NO20035458A patent/NO20035458D0/en not_active Application Discontinuation
- 2003-12-11 IL IL159345A patent/IL159345A/en not_active IP Right Cessation
-
2004
- 2004-08-12 HK HK04106071A patent/HK1063292A1/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002323873A1 (en) | Active ingredient combination of E.G. galanthamine or deoxypeganine and E.G. acamprosate or memantine for treating an addiction such as alcoholism | |
| WO2001098236A3 (en) | 7-phenyl-substituted tetracycline compounds | |
| MXPA03008710A (en) | Compositions and methods of zearalenone detoxification. | |
| AU2001260513A1 (en) | Microcapsule well treatment | |
| AU2002345970A1 (en) | Stabilized compositions and processes of their preparation | |
| WO2002102388A3 (en) | Active ingredient combination of e.g. galanthamine or deoxypeganine and e.g. acamprosate or memantine for treating an addiction such as alcoholism | |
| AU2001272189A1 (en) | Configuration of implanted devices | |
| ZA200204019B (en) | Combination treatment for alcoholism and alcohol dependence. | |
| AU2002231206A1 (en) | Treatment of depression | |
| MXPA03003741A (en) | Methods and compositions for the treatment of diseases of the eye. | |
| WO2003063725A3 (en) | Methods of preventing and treating flavivirus infection in animals | |
| AU2002349268A1 (en) | Medicine for preventing and treating bromidrosis | |
| HUP0401577A3 (en) | Process for the preparation of 2,4-didezoxyhexoses and 2,4,6-tridezoxyhexoses | |
| AU2002337843A8 (en) | Processes for the preparation of substituted isoxazoles and 2-isoxazolines | |
| AU2002327174A1 (en) | Identification of antimicrobial agents | |
| AU2002342944A1 (en) | Fiberboards and processes for the preparation thereof | |
| AU2002251202A1 (en) | Intimins for the prevention or treatment of infections: i | |
| AU2335601A (en) | Treatment or prevention of diarrhea | |
| AU2002304733A1 (en) | Amino-aza-cyclohexanes for the treatment of malaria | |
| AU2002242488A1 (en) | Agents for the prevention and treatment of sexually transmitted diseases -ii | |
| AU2002252176A1 (en) | Composition and methods for the treatment and prevention of bovine mastitis | |
| AU2002308724A1 (en) | Two-part disinfecting systems and compositions and methods related thereto | |
| AU2002344855A1 (en) | Compounds and methods for the treatment or prevention of flavivirus infections | |
| AU2002344156A1 (en) | Granules containing one or more highly active substances and method for producing the same | |
| AU2002303821A1 (en) | Aryl-8-azabicyclo(3.2.1)octanes for the treatment of depression |